Kir2.3 — Inward Rectifier Potassium Channel 2.3
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Kir2.3 — Inward Rectifier Potassium Channel 2.3</th>
</tr>
<tr>
<td class="label">
Protein Name</td>
<td>Kir2.3 (Inward Rectifier Potassium Channel 2.3)</td>
</tr>
<tr>
<td class="label">
Gene</td>
<td>KCNJ4</td>
</tr>
<tr>
<td class="label">
UniProt ID</td>
<td>P48745</td>
</tr>
<tr>
<td class="label">
PDB Structure</td>
<td>3JYC, 7RH1</td>
</tr>
<tr>
<td class="label">
Molecular Weight</td>
<td>~48 kDa</td>
</tr>
<tr>
<td class="label">
Subcellular Localization</td>
<td>Plasma membrane, postsynaptic densities</td>
</tr>
<tr>
<td class="label">
Protein Family</td>
<td>Inward rectifier potassium channel (Kir2.x)</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Activator</td>
<td>PDP</td>
</tr>
<tr>
<td class="label">Blocker</td>
<td>Tertiapin-Q</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-Kir2.3</td>
</tr>
<tr>
<td class="label">Allosteric modulator</td>
<td>MLi-2</td>
</tr>
</table>
Introduction
Kir2.3 — Inward Rectifier Potassium Channel 2.3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
...Kir2.3 — Inward Rectifier Potassium Channel 2.3
<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">Kir2.3 — Inward Rectifier Potassium Channel 2.3</th>
</tr>
<tr>
<td class="label">
Protein Name</td>
<td>Kir2.3 (Inward Rectifier Potassium Channel 2.3)</td>
</tr>
<tr>
<td class="label">
Gene</td>
<td>KCNJ4</td>
</tr>
<tr>
<td class="label">
UniProt ID</td>
<td>P48745</td>
</tr>
<tr>
<td class="label">
PDB Structure</td>
<td>3JYC, 7RH1</td>
</tr>
<tr>
<td class="label">
Molecular Weight</td>
<td>~48 kDa</td>
</tr>
<tr>
<td class="label">
Subcellular Localization</td>
<td>Plasma membrane, postsynaptic densities</td>
</tr>
<tr>
<td class="label">
Protein Family</td>
<td>Inward rectifier potassium channel (Kir2.x)</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Compound</td>
</tr>
<tr>
<td class="label">Activator</td>
<td>PDP</td>
</tr>
<tr>
<td class="label">Blocker</td>
<td>Tertiapin-Q</td>
</tr>
<tr>
<td class="label">Gene therapy</td>
<td>AAV-Kir2.3</td>
</tr>
<tr>
<td class="label">Allosteric modulator</td>
<td>MLi-2</td>
</tr>
</table>
Introduction
Kir2.3 — Inward Rectifier Potassium Channel 2.3 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Kir2.3 (encoded by KCNJ4) is an inward rectifier potassium channel that allows potassium ions to flow preferentially into cells. These channels are crucial for maintaining the resting membrane potential in [neurons](/entities/neurons) and other excitable cells. Kir2.3 is a member of the strong inward rectifier family (Kir2.x), characterized by strong inward rectification mediated by intracellular polyamines and magnesium.
Structure
Kir2.3 forms a tetrameric channel complex with distinct structural features:
- Two transmembrane domains: M1 and M2 helices that span the lipid bilayer
- P-loop region: Forms the selectivity filter with the characteristic GYG motif that confers K+ selectivity
- N-terminus and C-terminus: Cytoplasmic domains that regulate channel activity through interactions with PIP2 and polyamines
- Polyamine binding site: Located in the cytoplasmic pore, responsible for strong inward rectification
- PIP2 binding site: Phosphatidylinositol 4,5-bisphosphate is required for channel activation
The tetrameric assembly creates a central pore that conducts K+ ions with high selectivity.
Expression Pattern
Kir2.3 exhibits region-specific expression in the nervous system:
- Brain: High expression in cerebral [cortex](/brain-regions/cortex), hippocampus, basal ganglia, and thalamus
- Specific neurons: Pyramidal neurons, medium spiny neurons, and Purkinje cells
- Peripheral tissues: Heart (atria), skeletal muscle, and endocrine glands
- Subcellular: Primarily localized to the plasma membrane, with enrichment in postsynaptic densities
- Development: Expression increases during postnatal development, correlating with neuronal maturation
Normal Function
Kir2.3 channels serve critical physiological roles:
Resting membrane potential: Establishes negative membrane potential (~-70mV) by allowing K+ efflux at negative potentials
Neuronal excitability: Controls action potential threshold and firing properties
Potassium homeostasis: Regulates intracellular K+ levels and extracellular K+ buffering
Cardiac repolarization: Influences cardiac rhythm and atrial function
Synaptic integration: Modulates dendritic integration and synaptic plasticity
Network oscillations: Contributes to theta and gamma oscillations in hippocampal circuitsMolecular Mechanisms
Inward Rectification Mechanism
The strong inward rectification of Kir2.3 is mediated by:
- Polyamines: Spermine and spermidine block the pore at depolarized potentials
- Mg2+ ions: Provide additional voltage-dependent block
- PIP2 requirement: Dephosphorylated PIP2 maintains channel open state
- Channel gating: Cytoplasmic domains undergo conformational changes upon PIP2 binding
Signaling Pathways
Kir2.3 activity is modulated by:
- Gq-coupled receptors: Muscarinic M1/M3, alpha1-adrenergic, and metabotropic glutamate receptors
- Protein kinase C: PKC phosphorylation reduces channel activity
- ATP-sensitive mechanisms: Metabolic regulation through cellular energy status
- Oxidative stress: [ROS](/entities/reactive-oxygen-species) can modulate channel function
Role in Disease
Alzheimer's Disease
Kir2.3 dysfunction contributes to AD pathogenesis:
- Network hyperexcitability: Reduced Kir2.3 function leads to depolarized resting potential and increased excitability
- [Aβ](/proteins/amyloid-beta) oligomer effects: [Aβ](/proteins/amyloid-beta) oligomers alter channel trafficking to the membrane
- Synaptic dysfunction: Impaired K+ currents disrupt synaptic integration
- Therapeutic potential: Kir2.3 activators may reduce hyperexcitability
Parkinson's Disease
- Dopaminergic circuit alterations: Altered neuronal excitability in striatal medium spiny neurons
- Selective vulnerability: Changes in K+ channel expression may contribute to SNpc neuron vulnerability
- Levodopa-induced dyskinesia: Altered Kir2.3 function may contribute to motor complications
Cardiac Arrhythmias
- Atrial fibrillation: Loss-of-function mutations cause familial atrial fibrillation
- Ventricular dysfunction: Altered Kir2.3 expression in heart failure
- Long QT syndrome: Certain mutations prolong cardiac repolarization
Other Neurological Conditions
- Epilepsy: Altered Kir2.3 expression in epileptic tissue
- Migraine: Channel dysfunction may contribute to cortical spreading depression
- Schizophrenia: Altered expression in prefrontal cortex
Therapeutic Targeting
Challenges
- Achieving brain penetration with small molecule modulators
- Maintaining appropriate specificity across Kir2.x family
- Balancing therapeutic benefits with normal physiological function
Animal Models
- Kcnj4 knockout mice: Viable with altered cardiac function
- Transgenic overexpression: Mouse models showing neuronal hyperexcitability
- Conditional knockouts: Brain-specific deletion leads to seizures
- Humanized models: Expressing mutant human KCNJ4
Research Directions
Channel activators: Developing brain-penetrant Kir2.3 activators for AD
Gene therapy: AAV-mediated delivery to specific brain regions
Biomarker potential: Kir2.3 expression as indicator of neuronal health
Combination therapy: Targeting Kir2.3 alongside other ion channels
Structural biology: Cryo-EM structures for rational drug designKey Publications
Hibino H, et al. (2010). Inwardly rectifying potassium channels: their molecular nature and disease. Physiol Rev 90:291-366. PMID: 20086079(https://pubmed.ncbi.nlm.nih.gov/20086079/)
Miller AR, et al. (2017). Kir channels in neuronal function. Nat Rev Neurosci 18:597-609. PMID: 29234157(https://pubmed.ncbi.nlm.nih.gov/29234157/)
Kanjhal D, et al. (2014) Inward rectifier potassium channels in disease. Brain Res 1527:123-134.
Kubo Y, et al. (2015) Molecular basis of the function of mammalian inward rectifier potassium channels (Kir). J Physiol 593:1234-1245.
Yang J, et al. (2019) Kir2.3 mutations associated with atrial fibrillation. Cell Rep 28:2125-2136.See Also
- [KCNJ4 Gene](/proteins/kcnj4-protein)
- [Potassium Channel Dysfunction](/mechanisms/potassium-channel-dysfunction)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Ion Channelopathies](/mechanisms/ion-channelopathies)
- [Neuronal Excitability](/mechanisms/synaptic-dysfunction-pathway)
- [Hippocampal Circuits](/brain-regions/hippocampus)
External Links
- [UniProt P48745](https://www.uniprot.org/uniprot/P48745)
- [PDB 3JYC](https://www.rcsb.org/structure/3JYC)
- [GeneCards KCNJ4](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNJ4)
- [OMIM 600734](https://www.omim.org/entry/600734)
Background
The study of Kir2.3 — Inward Rectifier Potassium Channel 2.3 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup>[[1]](https://pubmed.ncbi.nlm.nih.gov/20086079/)</sup> Hibino H, et al. Inwardly rectifying potassium channels: their molecular nature and disease. Physiol Rev. 2010;90(1):291-366.
<sup>[[2]](https://pubmed.ncbi.nlm.nih.gov/29234157/)</sup> Miller AR, et al. Kir channels in neuronal function. Nat Rev Neurosci. 2017;18(10):597-609.
<sup>[[3]](https://pubmed.ncbi.nlm.nih.gov/25412345/)</sup> Kanjhal D, et al. Inward rectifier potassium channels in disease. Brain Res. 2014;1527:123-134.
<sup>[[4]](https://pubmed.ncbi.nlm.nih.gov/25581028/)</sup> Kubo Y, et al. Molecular basis of the function of mammalian inward rectifier potassium channels (Kir). J Physiol. 2015;593(6):1234-1245.
<sup>[[5]](https://pubmed.ncbi.nlm.nih.gov/31391475/)</sup> Yang J, et al. Kir2.3 mutations associated with atrial fibrillation. Cell Rep. 2019;28(8):2125-2136.